Expression of PD-L1 was observed in alveolar rhabdomyosarcoma (86%), rhabdomyosarcoma (2–50%), neuroblastoma (14–72%), Ewing sarcoma (0–57%), osteosarcoma (5–47%), and glioblastoma multiforme (36%) [155]. This evidence concerns the gene CD274 and rhabdomyosarcoma.